EMEA-000827-PIP01-09-M04

  • Email
  • Help

Overview

Product details for Cayston
Invented nameCayston
Active substance

Aztreonam

Decision numberP/0064/2016
PIP numberEMEA-000827-PIP01-09-M04
Pharmaceutical form(s)Powder and solvent for nebuliser solution
Condition(s)/indication(s)

Treatment of Pseudomonas-aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis

Route(s) of administrationInhalation use
PIP applicant

Gilead Sciences International Limited
United Kingdrom
Tel. +44 (0)1223 897300
Fax +44 (0)1223 897284
E-mail: regulatory.pip@gilead.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision